Seminars in Cancer Biology

Introduction: Epstein-Barr virus and non-B cell tumours
pp. 163-164(2)
Author: Young L.S.

Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma
pp. 165-174(10)
Authors: Niedobitek G.; Agathanggelou A.; Nicholls J.M.

Epstein-Barr virus and gastric carcinoma
pp. 175-182(8)
Authors: Osato T.; Imai S.

Epstein-Barr virus in Hodgkin's disease
pp. 183-189(7)
Author: Herbst H.

Epstein-Barr virus and human T-cell lymphomas
pp. 191-196(6)
Authors: Meijer C.J.L.M.; Jiwa N.M.; Dukers D.F.; Oudejans J.J.; de Bruin P.C.; Walboomers J.M.M.; van den Brule A.J.C.

EBV infection of T cells: potential role in malignant transformation
pp. 197-207(11)
Authors: Kelleher C.A.; Dreyfus D.H.; Jones J.F.; Gelfand E.W.

Are particular Epstein-Barr virus strains linked to disease?
pp. 209-215(7)
Authors: Jenkins P.J.; Farrell P.J.

Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma
pp. 217-226(10)
Authors: Ambinder R.F.; Robertson K.D.; Moore S.M.; Yang J.